Please login to the form below

Not currently logged in
Email:
Password:

GlycoVaxyn

This page shows the latest GlycoVaxyn news and features for those working in and with pharma, biotech and healthcare.

GSK's pivotal TB vaccine could prevent millions of deaths

GSK's pivotal TB vaccine could prevent millions of deaths

GSK has made vaccines a pillar of its strategy since taking control of Novartis’ vaccine business in 2014, which it then followed up with a $190m deal for vaccine specialist GlycoVaxyn

Latest news

  • GSK buys vaccine specialist GlycoVaxyn for $190m GSK buys vaccine specialist GlycoVaxyn for $190m

    Acquisition will expand GSK’s early vaccines pipeline.  . GlaxoSmithKline (GSK) has taken control of Swiss company GlycoVaxyn in a $190m deal that bolsters its early vaccines pipeline. ... GSK already owned a stake in GlycoVaxyn and had been working

  • Janssen boosts vaccines pipeline with GlycoVaxyn deal

    He said: “This collaboration is a further confirmation of the position GlycoVaxyn is about to occupy in the vaccine development space. ... The whole team is dedicated to establish GlycoVaxyn's technology as a powerful platform able to generate

More from news
Approximately 2 fully matching, plus 1 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 800 experts delivering world-class...

Latest intelligence

How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
Deep 6 AI: the smart software breathing new life into clinical trials
Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....
COVID-proof: How Teams are Creating Launch Intensity thru Adversity
Now that the game has changed, how are marketers shifting their launch behaviour? We've identified 5 common observations from effective teams....